Suction Drain Volume following Axillary Lymph Node Dissection for Melanoma-When to Remove Drains? A Retrospective Cohort Study.

Postoperative complications such as seroma formation and wound-site infection occur following completion axillary lymph node dissection (ALND) for melanoma. We analyzed the impact of time-to-drain removal and drainage volume on seroma formation after ALND. We retrospectively analyzed data from 118 patients after completion ALND for melanoma. Primary endpoints were daily amount of drainage volume, seroma formation and time-to-drain removal. Secondary endpoints included patient-related, disease-specific and perioperative parameters as well as the number of histologically analyzed lymph nodes and surgical complications graded by the Clavien−Dindo classification (CDCL). Statistical analyses were performed using logistic regression models. Drain removal around the 8th postoperative day was statistically associated with a lower risk for the occurrence of seroma formation (p < 0.001). Patients with an increased drainage volume during the early postoperative days were more prone to develop seroma after drain removal. With 49% (CDCL I and II), most complications were managed conservatively, while only 5.9% (CDCL III) required revision surgery (CDCL overall: 55.9%). ALND is a safe procedure with a low rate of severe CDCL III type of complications. To decrease seroma evacuation, our results imply that drains should be removed around the 8th postoperative day to reduce the risk of infection, readmission or prolonged hospitalization.

A Randomized Controlled Trial of Three Advanced Wound Dressings in Split-Thickness Skin Grafting Donor Sites-A Personalized Approach?

Background: Split-thickness skin grafting (STSG) is a frequently used reconstructive technique, and its donor site represents a standardized clinical model to evaluate wound dressings. We compared hydroactive nanocellulose-based, silver-impregnated and ibuprofen-containing foam wound dressings. Methods: A total of 46 patients scheduled for elective surgery were evaluated on the STSG donor site for wound healing (time-to-healing, Hollander Wound Evaluation Scale), pain level (Visual Analogue Scale), and handling (ease of use), as well as scar quality (Patient Scar Assessment Scale, Vancouver Scar Scale) after 3, 6 and 12 months. Results: Almost all dressings compared equally well. We observed statistically relevant differences for pain level favoring the ibuprofen-containing dressing (p = 0.002, ΔAIC = 8.1), and user friendliness in favor of nanocellulose (dressing removal: p = 0.037, ΔAIC = 2.59; application on patient: p = 0.042, ΔAIC = 2.33; wound adhesion: p = 0.017, ΔAIC = 4.16; sensation on skin: p = 0.027, ΔAIC = 3.21). We did not observe any differences for wound healing across all groups. Treatment with hydroactive nanocellulose and the ibuprofen-containing foam revealed statistically relevant better scar appearances as compared to the silver wound dressing (p < 0.001, ΔAIC = 14.77). Conclusion: All wound dressings performed equally well, with the detected statistical differences hinting future directions of clinical relevance. These include the reserved use of silver containing dressings for contaminated or close to contaminated wounds, and the facilitated clinical application of the nanocellulose dressing, which was the only suitable candidate in this series to be impregnated with a range of additional therapeutic agents (e.g., disinfectants and pain-modulating drugs). Personalized donor site management with the tested dressings can meet individual clinical requirements after STSG and improve management strategies and ultimately patient outcomes.

[First Experiences with peripheral Nerve Stimulation using an implantable System as a Treatment Method for the Complex Regional Pain Syndrome CRPS 2]. / Erste Erfahrungen mit der peripheren Nervenstimulation mittels implantierbarem System als Behandlungsmethode des komplexen regionalen Schmerzsyndroms CRPS 2.

INTRODUCTION: Peripheral nerve stimulation (PNS), based on central nerve stimulation (Spinal Cord Stimulation - SCS), has proven to be a suitable therapy option for the treatment of complex regional pain syndrome (CRPS), especially in the area of the upper extremities. However, the evidence on PNS in the current literature is very scarce. MATERIAL AND METHODS: 11 patients suffering from CRPS 2 were selected for implantation of a peripheral nerve stimulation system according to strict selection criteria. There were 5 men and 6 women with a mean age of 46.4 (24-58) years. Preoperatively, the mean pain score quoted by the patients was 8.0 (±1.3) on the ten-part numeric rating scale (NRS). In 8 patients, electrodes were implanted in the upper extremity (brachial plexus), in 2 patients in the area of the lower extremity (sciatic nerve) and in one patient on both the upper and lower extremities. The 8 active electrode poles were implanted as parallel as possible on the target nerves and connected to an external stimulation device by means of extension electrodes. After a test phase of 5 days, with positive feedback by the patients and a pain reduction of at least 4 points on the NRS, objectified by a pain log kept by the patient, the definitive impulse generator was implanted. RESULTS: All 11 patients were successfully supplied with an implantable peripheral nerve stimulation system from Boston Scientific Inc. The mean pain reduction was 4.6 (±1.2) points on the NRS. The mean pain score postoperatively was 3.4 (±0.9). The postoperative course was uncomplicated in all patients. CONCLUSION: Peripheral nerve stimulation appears to be a suitable therapy option for the treatment of CRPS 2 when conservative and conventional surgical treatment methods have failed. The experience with our patients shows that neuropathic pain could be successfully reduced by an average of about 4 points on the NRS. Arthrogenous symptoms, on the other hand, were not influenced by the PNS. Since CRPS is a psychosomatic illness, the integration of PNS into a multimodal therapy concept with physiotherapy and occupational therapy and psychology is essential for the success of the treatment.

Platelet-rich plasma for striae distensae: What do we know about processed autologous blood contents for treating skin stretchmarks?-A systematic review.

Striae distensae, also known as stretch marks, particularly associated with female sex, pregnancy, obesity, and/or hormonal change, are linear bands of benign dermal lesions. Although not posing any health risk, aesthetically unpleasing stretch marks can cause significant psychological distress among those affected. In abundance of therapeutic approaches, some literature sources proclaim platelet-rich plasma to be a promising treatment modality for striae distensae. We aimed to shed some light on the current literature evidence of platelet-rich plasma for treating stretch marks and performed an English literature analysis with two independent reviewers in accordance with PRISMA guidelines searching the PubMed and Web of Science databases in June 2019. Of the 12 found studies, 6 matched inclusion criteria. With no control groups in two, just two other reports used intraindividual comparisons, and all but one publication performed histopathological assessments. All studies observed clinical and subjective improvements without using validated scores or patient-reported outcome measures (PROMs). The main findings were that multiple treatments with platelet-rich plasma demonstrated increased epidermal thickness, rete ridges formation, and collagen/elastin formation, while decreasing the inflammatory cell infiltrate. The current literature evidence supporting the use of platelet-rich plasma for striae distensae is poor. We propose in this review an outline for a study protocol with intraindividual control groups, standardised scores, validated PROMs, and participant incentives to enhance the scientific power in future clinical trials.

[COVID-19 and plastic surgery: aesthetic surgery or essential medical care? - Impact of the COVID-19 pandemic on patient care in the plastic surgery department at an university hospital]. / COVID-19 und Plastische Chirurgie ­ Schönheitschirurgie oder wichtiger Bestandteil der medizinischen Versorgung?

INTRODUCTION: In spring 2020, the COVID-19 pandemic required far-reaching changes and measures of unprecedented extent. These measures were implemented to reduce virus spread and to ensure the continuity of nation-wide medical care, in particular with a view to having sufficient intensive-care capacities in case of a large caseload of patients infected with COVID-19. With regard to surgical specialties, this implied a temporary hold on elective cases for an indefinite period of time. The aim of this study was to assess the impact of these measures on the caseload of a level-three plastic surgery unit. METHODS: This study retrospectively assessed the caseload at the Division of Plastic, Aesthetic and Reconstructive Surgery at Medical University Graz during the so-called lockdown from 16 March 2020 to 27 April 2020 (6 weeks) as well as two weeks before. The data was compared with the corresponding time period of the year 2019. Surgical spectrum, procedural urgency, medical indication of surgical procedures as well as complication rates were compared. RESULTS: The suspension of elective cases led to a significant reduction in caseload of 57.5 % (2019: 353, 2020: 150 cases). There was a significant increase in emergency and acute case procedures performed during the lockdown compared with the previous year (2019: 41, 2020: 58 cases, p < 0.001). Furthermore, the number of self-inflicted injuries and suicide attempts increased significantly (2019: 0, 2020: 16 cases, p < 0.001). With regard to private and work-related injuries, there was no significant difference. Also, there was no difference in complication rates (2019: 6.8, 2020: 10 %, p = 0.219). CONCLUSION: A significant amount of surgical procedures in plastic surgery at a supraregional academic health centre consists of emergency, acute and urgent medically necessary cases. During the lockdown, surgical procedures were performed without a significant increase in complication rates. Despite challenges during the pandemic, high-quality patient care was provided throughout. To process less urgent yet important cases accumulated during the lockdown in a reasonable amount of time and maintaining the same level of high-quality care, additional capacities regarding operating rooms, hospital beds and outpatient care are needed. These results point out the importance of plastic surgery for medical care, in particular during times of crisis.

Burns in pandemic times - The Graz way towards COVID-19 and back.

The first half of the year 2020 has been shaped by quarantines and lock-downs all over the world. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic, that slowed down not only social interactions and economy, but also medical and health care. Governments and hospitals were forced to create ad hoc emergency plans maintaining the balance between an adequate participation in collective response of shutting-down to avoid a further spreading of the virus, while preserving the ongoing acute care and simultaneously being able to react to an imminent overextension with a collapse of capacities. The University Hospital Graz is one of the largest hospitals in Austria. As transregional trauma and burn centre it provides care for people from all over Austria and faced special challenges. We present the strategy of the University Hospital Graz in dealing with the COVID-19 pandemic and the way back to (new) normality. The strategy includes infrastructural, patient-centred and staff-centred measures. The continuously low numbers of new infections in Austria allowed a loosening of the lock-down measures already. Particular attention has to be paid to attentive screening of patients and triaging of surgeries during the re-boot. The re-boot needs to be slow and steady to reduce the risk of an infectiological relapse. Once this pandemic is defeated, a careful re-evaluation of the different internationally applied strategies should be performed to be prepared for the future.

Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma.

An 82-year-old woman presented with a 9-month history of multiple, well-defined skin lesions on her neck and upper chest, progressively increasing in size. Histological examination of a skin biopsy showed a regular epidermis. In the dermis, granulomatous changes with central necrobiosis were found which extended focally into the subcutaneous fat. The necrobiotic areas were surrounded by Touton cells and foreign-body giant cells. Laboratory analysis revealed leucopenia. Serum electrophoresis and immunofixation disclosed the presence of an IgG-λ paraprotein. Bone marrow aspiration cytology showed 20% plasmatic cells. The skeletal X-ray revealed frontal and occipital osteolytic skull lesions as well as pubic osteolysis. Urinalysis was unremarkable without proteinuria. Based on the clinical, laboratory, and histological findings, necrobiotic xanthogranuloma in association with multiple myeloma was diagnosed. The patient was treated with bortezomib combined with oral dexamethasone. Follow-up at week 13 revealed the complete disappearance of the IgG paraproteinemia. However, the skin lesions remained unchanged. Therefore, bortezomib treatment was discontinued, and systemic corticosteroids were continued at a higher dosage. After the steroid treatment, the lesions markedly flattened.